Sarah Sanghavi
Intensivist, Nephrologist @uwnephrology.bsky.social | Via UT Austin, UTSW, WashU, and Mt. Sinai | Views mine
nephrology.uw.edu/people/faculty/sang…
#nephsky #medsky
- Reposted by Sarah Sanghavi
- Reposted by Sarah Sanghavi
- Reposted by Sarah SanghaviHey #Medsky and #Pulmsky, check on your ICU nurse friends. I am and will always be grateful for my time and training at a VAMC ICU. The nurses there were wonderful humans who helped a tired, sometimes struggling new doc through difficult shifts. Cheers to the #ICUNurses, we lost a great one today.
- Reposted by Sarah SanghaviAlex Pretti was a colleague at the VA. We hired him to recruit for our trial. He became an ICU nurse- I lover working with him. He was a good kind person who lived to help and these fuckers executed him. White. Hot. Rage.
- Reposted by Sarah SanghaviWow Minneapolis today
- Reposted by Sarah Sanghavi🎉 Join in congratulating the 2026 ASN Loan Mitigation Program recipients. These future leaders of kidney health are shaping what comes next, and this program supports their path forward. Meet the recipients: bit.ly/asnLMP26
- Reposted by Sarah SanghaviAn announcement from Noah Wyle and the CDC:
- Reposted by Sarah Sanghavi[This post could not be retrieved]
- New year, new publication. Great working on this article on sepsis-associated AKI with @shinamenon.bsky.social, Pavan Bhatraju, and Javier Neyra. Currently, free to access. #nephsky #emimcc @uwnephrology.bsky.social authors.elsevier.com/a/1mNWkzzky3...
- Reposted by Sarah SanghaviEarlier: Gu's dream of an academic future in Houston ended in an airless limbo room where the lights never dimmed and the temperatures hovered at around 60 degrees. Instead of entering school, he's now banned from re-entering the U.S. For 5 years.
- This very short article offers a perspective of AI in higher education: "Difficulty is good, an end in its own right." www.theatlantic.com/ideas/2025/1...
- Division holiday party with the best people! @uwnephrology.bsky.social #nephsky
- Appreciate this excellent work showing GLP-1 agonists reduce mortality in patients on dialysis and improve their chances of receiving a transplant. Hopefully, it will help me get them approved for my patients through the VA. #nephsky journals.lww.com/cjasn/pages/...
- Reposted by Sarah SanghaviHave an upcoming conference you want highlighted on a specialty feed? Want help setting up community handles for your organization? Want to make a feed on your account to showcase posts from your medical faculty? The sky is the limit & @medsky.social is here to help! Email support@medsky.social
- IV iron improves outcomes even in people with bacterial infections (except meningitis). Observational study of 85K patients to be presented Sunday 12/7 at ASH. #nephsky www.hematology.org/newsroom/pre...
- Reposted by Sarah SanghaviThank you for this reporting @apoorvanyt.bsky.social www.nytimes.com/2025/12/05/h...
- Reposted by Sarah SanghaviWhat do you want to see at #KidneyWk 2026? Now’s the time to shape it. Submit your session and faculty suggestions for next year’s program in Denver by Monday, December 15. Don’t wait—add your ideas before the call closes. 👉 asn.kdny.info/WjFe50XBix7
- It was really interesting researching this topic. Hope it’s useful.
- Dr. Sarah Sanghavi (@sarahsanghavi.bsky.social) presents "Prolonging Circuit Life in CRRT" and discusses the consequences of CRRT interruptions as well as strategies to improve circuit life. #vascular #antigoagulation #kidney #nephrology #nephsky @uwmedicine.bsky.social youtu.be/JnOa6yQtPfQ
- Reposted by Sarah SanghaviAre you a peds resident who didn't match into fellowship yesterday, or someone wishes to do peds nephrology, we have a wonderful program waiting for you med.stanford.edu/pednephrolog... Come work & learn w/us in ☀️ Bay Area! Reach out to any of us @xgaeta.bsky.social @4kidney.bsky.social #NephSky
- Reposted by Sarah SanghaviIf you are a resident who didn’t match today, a hospitalist looking for change, or anyone looking to join an amazing and innovative fellowship program in an unbeatable location we have a Nephrology spot open for you! Contact us if you are interested! ohsu.edu/school-of-medi…
- Reposted by Sarah SanghaviWhat a Match! We are thrilled to welcome this exceptional group of doctors to our UW Nephrology Fellowship Program!! @uwnephrology.bsky.social @uwmedicine.bsky.social #Seattle #Match2026 #nephsky
- Reposted by Sarah SanghaviAll ELISAs that use biotin strepavidin at risk for this. Which are pretty much all ELISAs
- Biotin was recommended for one of my kidney transplant patients for hair loss associated with tacrolimus. Oral doses may interfere with PTH assays.
- Oncologists, B7 beware: dermatologists from #OSUWexMed sharing a call to action for oncologists to ask patients about biotin use for hair regrowth in interpretation of TSH, PSA, estradiol, testosterone, and more. Beyond lab interference, limited evidence for efficacy. ascopubs.org/doi/10.1200/...
- Reposted by Sarah SanghaviWe had a great turnout for #Cranksgiving, biking food from local grocers to area food banks. Several folks donated funds directly. Everyone had a wonderful time! Over 6,500 lbs of food donated!! Happy Thanksgiving!! 🦃😀🚴♂️ @uwnephrology.bsky.social @uwdeptmedicine.bsky.social @uwmedicine.bsky.social
- Reposted by Sarah SanghaviIt was an honor for us to host Dr. Sandeep Mallipattu in #Seattle for Nephrology Grand Rounds! Take a look at his fantastic talk, "Treating FSGS: Something Old, Something New, Something Still in Motion." #kidney #nephrology #FSGS @uwmedicine.bsky.social #nephsky #meded youtu.be/Nu8VZHuVTdY
- Reposted by Sarah Sanghavi1/n Recently attended an international congress about Urinalysis in Santiago, Chile 🇨🇱. I was expecting a small meeting. I was wrong. Pleasantly surprised with the size of the meeting and the energy and interest from the participants. Let me share the highlights of my experience:
- Reposted by Sarah SanghaviCongrats to Dr. Karen de Wolski, selected for the 2026 @asnkidney.bsky.social FIND Pgrm! FIND - Fostering Innovative Leaders in #Nephrology & #Dialysis empowers future generations of neph pros to drive innovation, advance clinical care, and champion positive policy change. 👏👏👏@uwmedicine.bsky.social
- Increasing the Potassium Level in Patients at High Risk for Ventricular Arrhythmias | New England Journal of Medicine www.nejm.org/doi/full/10....
- Reposted by Sarah SanghaviI often hear "I wish we didn't have to waste these expensive meds every time a patient stops & has extra left over." Here's what the state of Michigan did to combat this: - Statewide cancer drug repository, 105 sites - $26 million value/>100K pills donated to >1K pts ascopubs.org/doi/10.1200/...
- Fun in the Houston airport! @uwnephrology.bsky.social #kidneywk
- Ian McCoy describing higher rates of intradialytic hypotension with more frequent HD in AKI-D including the fresh off the press LIBERATE-D. #kidneywk
- Dr. Babroudi quantifying the problem-it affects about 10,000 patients per year in the US. #kidneywk
- A much needed study evaluating an intervention for renal recovery in people with AKI requiring dialysis. jamanetwork.com/journals/jam... #kidneywk
- A much needed study evaluating an intervention for renal recovery in people with AKI requiring dialysis. jamanetwork.com/journals/jam... #kidneywk
- After empa-kidney, it still wasn’t clear what to do for patients with CKD without diabetes or albuminuria. This meta-analysis suggests you use flozins. #kidneywk jamanetwork.com/journals/jam...
- Reposted by Sarah SanghaviThe 4 pillars of CKD management: RAASi SGLT2i MRA GLP-1 agonists #KidneyWk Dr Perkovic calls for combination therapy, but need properly run trials.
- Reposted by Sarah SanghaviOn the cover, a new analysis of the SELECT trial confirms semaglutide lowers the risk of major heart problems in people who are overweight or obese and already have heart disease, even if they don’t have diabetes. 🫀 Read this & more in our new issue: tinyurl.com/58p97aud
- Excellent discussion by @lizkiernanmd.bsky.social on the use of subphenotypes in sepsis-associated AKI for trial enrollment and prognostication. #kidneywk
- Reposted by Sarah SanghaviSubphenotyping can change answers. In CLOVERS: SP2 (“leaky endothelium”) had lower mortality with early vasopressors (restrictive fluids), while SP1 favored fluids. EUPHRATES/TIGRIS: endotoxin 0.6–0.9 subgroup signaled benefit → smarter, targeted trials. #KidneyWk #Sepsis #AKI
- Reposted by Sarah SanghaviThe Eknoyan Lectureship at #KidneyWk will cover KDIGO Guidelines for CKD on Saturday. Read about the speaker in #ASNKidneyNews kidney.pub/KN1710-55
- Excellent talk by @nephcrit.bsky.social on precision dose CRRT. #kidneywk
- Reposted by Sarah Sanghavi[Not loaded yet]
- Reposted by Sarah SanghaviForgot to post the two at plenary on Thursday FINEONE: finerenone in T1DM ORIGIN: Atacicept (pronounced attack-e-sept) in IgAN (pronounced eye-gee-A-N) Possible NEJM or Lancet simulpubs? #KidneyWk
- Reposted by Sarah Sanghavi(1/3) Paying close attention to morphologic detail can sometimes suggest etiologic clues in cases of severe chronic renal injury. The glomerulus in this image, for example, shows near complete global glomerulosclerosis. #TeachingPoints #kidneypath #nephsky #pathsky #renal
- Reposted by Sarah Sanghavi$18 Mocktail Satisfies Craving To Waste Money theonion.com/18-mocktail-satisfi…
- I think this was the expected finding based on the original BICAR-ICU trial. In that one, 52% of the control group received RRT (and therefore bicarb) with a mean of 7 hours from enrollment. With poor separation of treatment arms, it’s hard to attribute the mortality benefit to the intervention.
- The BICAR-ICU-2 trial just dropped! RCT involving IV bicarb in metabolic acidosis among patients with mod-severe AKI Bicarb didn't affect mortality but it reduced the need for dialysis & risk of bacteremia VERY similar conclusions to BICAR-ICU-1 🧵 #1/ jamanetwork.com/journals/jam... #EMIMCC
- Reposted by Sarah SanghaviMixed cellular containing RBCs, WBCs (blue) and RTECs (fuchsia) in the #UrinarySediment from a patient with suspected IgA nephropathy 🔬bright field (500x) and oblique illumination (1000x) #UrineMicroscopy #OchsnerNephrology
- Reposted by Sarah SanghaviHighlighted in @washingtonpost.com, our research is fueling policy debates in D.C. Our @jama.com study shows Emergency Medicaid accounts for 0.4% of nationwide Medicaid spending. Led by @trishasantos.bsky.social @fumikochino.bsky.social www.washingtonpost.com/health/2025/...
- Reposted by Sarah SanghaviPretty sure it’s greater than 10% but less than 50%? Oh - the @asnkidney.bsky.social actually publishes this see www.asn-online.org/education/ki... etc ~ a third international, and by my calculation around 6% Canadians #KidneyWk
- Reposted by Sarah Sanghavi
The frogs have landed in Chicago! - Reposted by Sarah Sanghavi📢 Now available: the 12th annual ASN Nephrology Fellow Survey. This year’s report highlights salaries, job search experiences, and the demographics of those entering the field. In 2025, adult fellows reported a 4% increase in starting pay. 📊 🔗 bit.ly/4pV5FYl
- Reposted by Sarah SanghaviBold much-needed perspective by @sarahsanghavi.bsky.social et al about revisiting TIPS in the context of kidney disease, particularly in some cases of #HRS at #Kidney360 journals.lww.com/kidney360/ab...
- Reposted by Sarah SanghaviA Mariners fan’s shirt said, ‘Dump 61 here.’ So Cal Raleigh obliged — and the fan unveiled a second surprise ⤵️ dlvr.it/TNYJyN
- Reposted by Sarah Sanghavi"Never before have we issued a joint public warning like this." The latest from former U.S. surgeons general Jerome Adams, Richard Carmona, Joycelyn Elders, Vivek Murthy, Antonia Novello and David Satcher:
- Reposted by Sarah Sanghavi#foamed #medsky #emimcc Next week: how to manage the airway of a crashing critically ill patient with RV failure and severe ARDS
- Reposted by Sarah SanghaviInteresting pilot/feasibility trial in @kireports.bsky.social Decremental dialysis in elderly patients with small inter dialytic weight gains - going from 3 to 2x week HD. Easy to recruit, good adherence. www.kireports.org/article/S246...
- Reposted by Sarah SanghaviSo happy to be able to share my article on Seattle’s Fresh Bucks program! FB is a $40/month benefit that can be spent on fresh fruits and vegetables at all local Safeways, farmers markets, and some smaller grocers. It requires *no* SNAP enrollment and *no* matched spending… 🧵1/7
- Reposted by Sarah SanghaviMost viewed this week from JAMA: In patients with salvageable brain tissue identified by perfusion imaging who did not initially receive thrombectomy, alteplase given 4.5 to 24 hours after acute ischemic #stroke onset may improve functional outcomes. ja.ma/4oILnRs
- Reposted by Sarah SanghaviAcanthocyte - phase contrast (original mag x400) - from patient with hydralazine-induced vasculitis #UrineMicroscopy #UrinarySediment
- Reposted by Sarah SanghaviAdding the Hypertension journsl link! www.ahajournals.org/doi/10.1161/...
- Reposted by Sarah Sanghavi4) Stronger recs for home BP monitoring 5) Same BP goals and treatment initiation thresholds, now with PREVENT score to help guide initiation and with some nudges to consider going for an SBP <120 when tolerated 6) No more race-base recs /n
- Reposted by Sarah SanghaviNew 2025 AHA/ACC Hypertension Guideline dropped! www.jacc.org/doi/10.1016/... #hypertension #medsky #nephsky
- Reposted by Sarah SanghaviInternational guidelines recommend 5 to 7 days of antibiotic prophylaxis for patients with cirrhosis & upper GI bleeding. 🆕🔥Systematic Review ( 14 RCTs, N=1322) & Bayesian Meta-Analysis challenged this universally held dogma #idsky jamanetwork.com/journals/jam...
- Reposted by Sarah SanghaviVitamin R + Cyclophosohamide in ANCA vasculitis A case series from Edinburgh suggesting this allows faster steroid withdrawal? @kireports.bsky.social www.kireports.org/article/S246... #NephSky #Vasculitis
- Reposted by Sarah SanghaviWe are excited to kick off the new academic year with a #womeninnephrology event and welcome our new #nephrology fellows, Erin, Hanna, Heba, and Jessica to our WIN community @uwmedicine.bsky.social! #kidney #healthcare #research #nephsky #WomenInMedicine #AcademicLife
- Question for #nephsky #askrenal. Friend found these casts in a patient with multiple myeloma- Cr 0.8 and UPCR 0.1 g/g. They don’t look like typical hyaline casts. Any thoughts? @juancarlosqvelez.bsky.social @jrseltzer.bsky.social
- Reposted by Sarah SanghaviBREAKING: Texas Democrats head to Illinois to deny Republicans a quorum on redistricting
- Reposted by Sarah SanghaviNew Fellow Welcome Dinner!! @uwnephrology.bsky.social @uwmedicine.bsky.social #kidney #Seattle #nephsky #nephfellows 🫘🌲🩺😊
